Snappy newsletters. Simple Facebook sharing. Spirited comments. Sweet features are waiting… GET THEM NOW!

Hot on Facebook

'Serpent Pastor' Dies of Snake Bite Mack Wolford believed faith compelled him to face the risk »

Anti-Smoking Chantix, Zyban Pose Suicide Risk: FDA

Smokers with mental illnesses should avoid them, agency says

By Ambreen Ali, Newser User

Posted Jul 1, 2009 4:59 PM CDT

(Newser) – The Food and Drug Administration is warning smokers about serious mental-illness risks of two smoking-cessation drugs, as reported suicides among their users increase. Chantix and Zyban must now carry the agency’s strongest warning label, the New York Times reports. The FDA isn’t trying... Read full story »

COMMENTS

Read the comment policy

You need to Log in to Newser to comment. Don't have an account yet? Sign up now!

9 comments

A snapshot of the day's best news stories.

View Larger Grid

All Today Yesterday Pick a Date

What's Popular Now on Facebook

'Serpent Pastor' Dies of Snake Bite

Miami Face-Eater Identified

New York Times (Source Grid »)

Health • Money

FDA • pharmaceutical companies • GlaxoSmithKline • Pfizer • smoking cessation • Chantix • women's issues • Zyban

More Newser Stories

FDA May Strengthen Chantix Label

Anti-smoking drug linked to more seizures, accidents

(NEWSER) - The FDA may beef up its warning for the anti-smoking drug Chantix after an increase in the number of serious incidents linked to the drug, the Wall Street Journal reports. A drug-safety group tallied 1,001 reports of patients suffering seizures, blackouts, and loss of motor control—some while driving—in three months. The figure is more than the combined total of incidents linked to the top 10 prescription drugs. More»

Quit-Smoking Drug Linked to Heart Trouble, Dizziness

FAA bans pilots and air controllers from using Chantix after report

(NEWSER) - Pfizer smoking-cessation drug Chantix has been linked to nearly a thousand serious incidents in the last quarter of 2007, the Wall Street Journal reports. A report from a drug safety group found that some users of the drug—already linked to depression and suicide—suffered heart trouble, diabetes, or accidents caused by dizziness and confusion. More»

Disgraced Doctors Land at Big Pharma

Hundreds of pitchmen found to have blemished records

(NEWSER) - Pharmaceutical companies say they hire highly respected doctors as their white-coat sales force, peddling their drugs to other physicians. But a Pro Publica investigation has discovered that hundreds of these pitchmen have been accused of professional misconduct, been disciplined by state boards, or lacked credentials. Medical board records in the 15 most populous states revealed that more than 250 had been sanctioned, another 40 given FDA warnings for research lapses, and 20 more hit with successful malpractice lawsuits. Some have even lost their licenses. More»

Avandia Woes Mount Ahead of FDA Hearing

Agency flags flawed study, may ban diabetes drug

(NEWSER) - As the FDA prepares to consider whether to ban Avandia, agency scientists have discovered another problem with the diabetes drug: flaws that disqualify a clinical study sponsored by its maker. The trial, organized by GlaxoSmithKline, sought to evaluate the relative heart risks of Avandia and two other diabetes drugs, but was an "open label" trial, meaning the researchers and patients knew which drugs they were getting, USA Today reports. More»

Big Pharma Seeks Big Profits in Developing Nations

Drug Makers See Future in New Markets

(NEWSER) - The pharmaceutical industry is turning away from the US shores that helped fill its pockets and toward the developing world, the Economist reports. Massive growth has made markets like India and China too attractive to ignore, despite lower income levels and weaker patent laws. And many companies fear Barack Obama's health-care plans will mean major price cuts. More»

NEWS FROM OUR PARTNERS

What is Newser?

Face it: there's too much news. At Newser, we choose the most thought-provoking and entertaining stories from hundreds of US and international sources and reduce them to a headline, picture, and two paragraphs. And we do it 24/7—you can come back morning, noon, night (and in between) for something new that matters. Read less, know more.

Learn more »

Partnering with: Slate

View Newser on the mobile website

Anti-Smoking Chantix, Zyban Pose Suicide Risk: FDA

Smokers with mental illnesses should avoid them, agency says

FDA • pharmaceutical companies • GlaxoSmithKline • Pfizer • smoking cessation • Chantix • women's issues • Zyban

MOST POPULAR STORIES

[ By Views ]

[ By Comments ]

More Newser Stories

FDA May Strengthen Chantix Label

Anti-smoking drug linked to more seizures, accidents

Quit-Smoking Drug Linked to Heart Trouble, Dizziness

FAA bans pilots and air controllers from using Chantix after report

Disgraced Doctors Land at Big Pharma

Hundreds of pitchmen found to have blemished records

Avandia Woes Mount Ahead of FDA Hearing

Agency flags flawed study, may ban diabetes drug

Big Pharma Seeks Big Profits in Developing Nations

Drug Makers See Future in New Markets

About Us

Site

Community

Site Maps

Tools

More News

What is Newser?